← Back to Search

Behavioral Intervention

COGENT - Cognitive Training Intervention Program for Anxiety Disorders

N/A

Waitlist Available

Research Sponsored by University of California, San Diego

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 21-55

Diagnosis of mood, anxiety, or traumatic stress disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, week 4,week 8, week 16

Awards & highlights

Study Summary

This trial will test the effects of a computer-based cognitive training program on individuals with anxiety, depression, or traumatic stress symptoms. Participants will be split into two groups: one receiving the actual training program and

Who is the study for?

This trial is for individuals seeking treatment for anxiety, depression, or traumatic stress symptoms. Participants should be willing to undergo cognitive training and brain response assessments. Specific eligibility criteria are not provided but typically include age range, mental health status, and absence of conditions that could interfere with the study.Check my eligibility

What is being tested?

The trial is testing a computer-based cognitive training program called COGENT against a control exercise (Sham Program) thought to be less effective. Participants will be randomly assigned to one of these two groups and their thinking skills and brain responses will be compared before and after the intervention.See study design

What are the potential side effects?

Since this trial involves non-invasive cognitive training programs, side effects may be minimal but can include potential discomfort from sitting at a computer for extended periods or possible frustration if tasks are challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 21 and 55 years old.

Select...

I have been diagnosed with a mood, anxiety, or stress-related disorder.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, week 4,week 8, week 16

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, week 4,week 8, week 16

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, week 4,week 8, week 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in cognitive performance

Secondary outcome measures

Neuropsychological Performance

Reading Span Blood Oxygen Level Dependent (BOLD) Response

Repetitive Negative Thinking (RNT)

Other outcome measures

Anxiety Symptoms

Disability

Mood and Emotions

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: COGENT - Cognitive Training Intervention ProgramExperimental Treatment1 Intervention

Computer-administered cognitive training program. COGENT is a modified working memory capacity task designed to train cognitive functioning. COGENT was designed to contain high interference across trials. By requiring repeated practice with utilization of interference control across trials, COGENT is thought to enhance plasticity of cognitive systems and improve performance. That is, training is based on the premise that learning-based neural changes will occur via repeated exposure to a task demanding cognitive control resources

Group II: Non-Training ProgramPlacebo Group1 Intervention

The non-training condition requires participants to complete a similar computer task for the same length of time. The non-training is a modified working memory capacity task designed to be inert. The non-training condition was designed to contain relatively less interference demands across trials.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

COGENT

2021

N/A

~80

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San DiegoLead Sponsor

1,120 Previous Clinical Trials

1,521,279 Total Patients Enrolled

21 Trials studying Anxiety Disorders

1,238 Patients Enrolled for Anxiety Disorders

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals above the age of 60 eligible to participate in this clinical trial?

"Participants sought for this research project must be over 21 years old but under the age of 55."

Answered by AI

Which individuals are eligible to participate in this research investigation?

"Individuals aged between 21 and 55 with diagnosed anxiety disorders are eligible for participation in this clinical trial, which aims to enroll a total of 128 participants."

Answered by AI

Are participants currently being enrolled in this research study?

"Information available on clinicaltrials.gov indicates that recruitment for this particular trial is closed. Originally listed on 11/1/2024 and last updated on 2/15/2024, the study has ceased accepting candidates. Despite this, there are currently 1911 other active trials seeking participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)

Jessica Bomyea 2024. "Enhancing Transdiagnostic Mechanisms of Cognitive Dyscontrol (R33)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06273527.

All > Anxiety Disorder